The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays
- 7 January 2025
- journal article
- research article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 19 (1) , 1-12
Abstract
Purpose Oral squamous cell carcinoma (OSCC) is a significant public health challenge associated with high mortality rates primarily due to its invasive and metastatic behavior. This study aimed to evaluate the expression patterns of five critical biomarkers: β-catenin, E-cadherin, podoplanin (PDPN), CXCR4, and p53 in OSCC tissues and to investigate their correlations with clinicopathologic features and patient outcomes. Methods We conducted an immunohistochemical analysis utilizing tissue microarrays (TMAs) from 95 patients diagnosed with primary OSCC. The expression levels of the five biomarkers were quantified using H-scores. Statistical analyses, including Kruskal-Wallis tests, Dunn’s post-hoc tests, and correlation analyses, were performed to explore the associations between biomarker expression, clinicopathologic parameters, and overall patient survival. Results The study found that loss of E-cadherin and β-catenin expression was significantly associated with increased tumor depth and lymphatic invasion, corroborating their role in the process of epithelial-mesenchymal transition (EMT). High levels of PDPN were noted in both early and late-stage OSCC, indicating its potential involvement in initiating invasive behaviors. Notably, CXCR4 expression exhibited positive correlations with E-cadherin and β-catenin, suggesting a hybrid invasion phenotype incorporating both EMT and collective invasion strategies. Although Cox regression analysis did not reveal significant associations between biomarker expression and overall survival (OS) or disease-specific survival (DSS), factors such as alcohol consumption, tumor size, lymph node involvement, and advanced clinical stage emerged as significant negative predictors of both OS and DSS. Conclusion The expression profiles of β-catenin, E-cadherin, PDPN, CXCR4, and p53 in OSCC tissues provide valuable insights into a hybrid model of invasion that integrates mechanisms of EMT with an important rule in the tumor invasion. This nuanced understanding of OSCC progression highlights the potential of PDPN and CXCR4 as novel therapeutic targets, emphasizing the need for further investigation into their roles in OSCC biology and the development of targeted treatments that could improve patient outcomes and survival rates.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.932709/2024-00)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887.932709/2024-00)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (23/11402-4)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (10/51168-0)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (304389/2015-3)
This publication has 44 references indexed in Scilit:
- Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 2024
- CXCL12 is expressed by skeletal muscle cells in tongue oral squamous cell carcinomaCancer Medicine, 2022
- Expression of podoplanin in tumor cells and lymphatic vessels in both tumoral and peritumoral areas and correlation with metastatic potential of oral squamous cell carcinomaJournal of Oral and Maxillofacial Pathology, 2021
- Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunitiesInternational Journal of Cancer, 2020
- Epithelial–mesenchymal transition in tumor metastasisMolecular Oncology, 2016
- Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and TherapyCritical Reviews™ in Therapeutic Drug Carrier Systems, 2016
- Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2013
- Early stage squamous cell cancer of the oral tongue—clinicopathologic features affecting outcomeCancer, 2011
- The p53 tumor suppressor network in cancer and the therapeutic modulation of cell deathApoptosis, 2009
- Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.2007